ConductScience.org, home

Paper3918441

Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy.

Leichman L and 9 others. Am J Med, 1985. Cited by 169 papers, by iCite.

Cite this record

ConductScience Library. Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy. Papers, record 3918441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3918441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy.
PubMed
Journal
Am J Med
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
169
iCite
Relative citation ratio, by iCite
4.62
iCite
Revised in PubMed
2022-04-08
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leichman LL
2Nigro NN
3Vaitkevicius VKV K
4Considine BB
5Buroker TT
6Bradley GG
7Seydel HGH G
8Olchowski SS
9Cummings GG
10Leichman CC

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anus NeoplasmsMajor topic
Carcinoma, Squamous CellMajor topic
Carcinoma, Transitional CellMajor topic
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Female
Fluorouracil
Humans
Male
Middle Aged
Mitomycin
Mitomycins
Preoperative Care

Source PubMed

Download CSV of topics

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 169 citations.

PMIDTitleJournalYearIn PapersSource
42583074The historical perspective on anal cancer therapy: what have we learnt, where did we fail?ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/42583074PubMed
42582979Optimising chemoradiotherapy in anal cancer.ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/42582979PubMed
42238726More Than Just an Abscess: An Unusual Case of Anal Squamous Cell Carcinoma.ACG Case Rep J2026https://conductscience.org/library/papers/42238726PubMed
41653360SEOM-GEMCAD-TTD clinical guidelines for anal cancer (2025).Clin Transl Oncol2026https://conductscience.org/library/papers/41653360PubMed
41440221Outcomes of Anal Cancer Patients with Inflammatory Bowel Disease Treated with Curative Chemoradiotherapy: A Systematic Review of Current Evidence.Curr Oncol2025https://conductscience.org/library/papers/41440221PubMed
40936687Isolated hypoxic pelvic perfusion combined with electroporation is a valid alternative to traditional therapies for anal squamous cell carcinoma: a case study.Front Oncol2025https://conductscience.org/library/papers/40936687PubMed
40606940Anal cancer impact among people with HIV infection - a matched cohort study.Ecancermedicalscience2025https://conductscience.org/library/papers/40606940PubMed
39312693Anal carcinoma - exploring the epidemiology, risk factors, pathophysiology, diagnosis, and treatment.World J Exp Med2024https://conductscience.org/library/papers/39312693PubMed
39163501Treatment of stage I-III squamous cell anal cancer: a comparative effectiveness systematic review.J Natl Cancer Inst2025https://conductscience.org/library/papers/39163501PubMed
38735904Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer.Ann Surg Oncol2024https://conductscience.org/library/papers/38735904PubMed
38688457Rational treatment options for T1/2N0M0 squamous cell carcinoma of the anal canal: a population-based study combined with external validation.Oncologist2024https://conductscience.org/library/papers/38688457PubMed
38425766Outcomes of patients with anal cancer treated with definitive chemoradiation: A single centre experience.Ecancermedicalscience2024https://conductscience.org/library/papers/38425766PubMed
36975459Anal Cancer: The Past, Present and Future.Curr Oncol2023https://conductscience.org/library/papers/36975459PubMed
36241859Impact of marital status at diagnosis on the survival of patients with anal canal squamous cell carcinoma: a propensity score-matched analysis.Int J Colorectal Dis2022https://conductscience.org/library/papers/36241859PubMed
34850581Construction and validation of a prognostic nomogram for anal squamous cell carcinoma.Cancer Med2022https://conductscience.org/library/papers/34850581PubMed
34790484Definitive Radiotherapy for Patients With Anal Squamous Cell Carcinoma: A Retrospective Cohort Study.Cureus2021https://conductscience.org/library/papers/34790484PubMed
34663790Molecular and genomic characterisation of a panel of human anal cancer cell lines.Cell Death Dis2021https://conductscience.org/library/papers/34663790PubMed
33925282De-Escalation of Therapy for Patients with Early-Stage Squamous Cell Carcinoma of the Anus.Cancers (Basel)2021https://conductscience.org/library/papers/33925282PubMed
33801992Evolution of the Role of Radiotherapy for Anal Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/33801992PubMed
33486535Radiotherapy alone versus chemoradiotherapy for stage I anal squamous cell carcinoma: a systematic review and meta-analysis.Int J Colorectal Dis2021https://conductscience.org/library/papers/33486535PubMed

See all 55 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3918441

GET https://conductscience.org/api/papers/v1/3918441/cited_by?page=2